Patents
US 7816490 B2: Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
- Granted
- 2010-10-19
- Filed
- 2008-10-28 application 12260049
- Type
- Utility · 18 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.
Source: PVGPATDIS, file of 2026-04-10 (ipg101019.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Immune Disease Institute 8 patents | US company or organization | Boston, MA | Immune Disease Institute Inc Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Patrick Hogan | Cambridge, MA | 8 | PVGPATDIS, file of 2026-04-10 | |
| Anjana Rao | Cambridge, MA | 32 | PVGPATDIS, file of 2026-04-10 | |
| Jose Aramburu | Boston, MA | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07K | Peptides | C07K5/101 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K38/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2010-02-23 | Correction Corrective assignment to correct the name of the receiving party recorded march 27, 2009, from the center for blood research to center for blood research, inc. previously recorded on reel 022459 frame 0960. assignor(s) hereby confirms the patri | ARAMBURU, JOSE signed 1999-06-15 HOGAN, PATRICK G. signed 1999-06-15 RAO, ANJANA signed 1999-06-15 | CENTER FOR BLOOD RESEARCH, INC. BOSTON, MA | 23977/945 | ECORSEXC, file of 2026-09-25 |
| 2009-12-11 | Name change Change of name | THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. signed 2007-06-05 | IMMUNE DISEASE INSTITUTE, INC. BOSTON, MA | 23641/408 | ECORSEXC, file of 2026-09-25 |
| 2009-04-01 | Name change Change of name | CENTER FOR BLOOD RESEARCH, INC. signed 2003-08-12 | THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. BOSTON, MA | 22481/450 | ECORSEXC, file of 2026-09-25 |
| 2009-03-27 | Assignment Assignment of assignor's interest | ARAMBURU, JOSE signed 1999-06-15 HOGAN, PATRICK G. signed 1999-06-15 RAO, ANJANA signed 1999-06-15 | THE CENTER FOR BLOOD RESEARCH BOSTON, MA | 22459/960 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.